1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 35 (2) , 661-669
- https://doi.org/10.1038/ki.1989.36
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure.Journal of Clinical Investigation, 1987
- Altered divalent ion metabolism in early renal failure: Role of 1,25(OH)2DKidney International, 1985
- A Microassay for 1,25-Dihydroxyvitamin D Not requiring High Performance Liquid Chromatography: Application to Clinical Studies*Journal of Clinical Endocrinology & Metabolism, 1984
- Determinants of serum 1,25(OH)2D levels in renal diseaseKidney International, 1983
- A new semiautomatic method for quantitative static and dynamic bone histologyCalcified Tissue International, 1982
- Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiencyKidney International, 1982
- Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.BMJ, 1981
- Plasma Levels of Vitamin D Metabolites in Renal Diseases1Published by S. Karger AG ,1979
- DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROLThe Lancet, 1978
- Bone histology in incipient and advanced renal failureKidney International, 1976